Comparison | Number of trials (n) | Weighted event rates | RBI (95% CI) | NNT (CI) |
---|---|---|---|---|
*Abbreviations defined in glossary; RBI, NNT, and CI calculated from data in article. | ||||
Topical antibiotic v placebo | 5 (365) | 58% v 21% | 179% (108 to 274) | 3 (3 to 4) |
Topical mupirocin v oral erythromycin | 10 (581) | 91% v 85% | 7% (1 to 13) | 17 (9 to 100) |
Topical antibiotic v disinfecting treatment | 2 (292) | 72% v 62% | 15% (1 to 32) | Borderline significance |